Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.23.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Sales $ 6,698 $ 282
Cost of goods sold [1],[2] 6,419 234
Gross profit 279 48
Operating expenses:    
Research and development [1],[2] 3,576 1,948
Selling, general and administrative [1],[2] 15,981 22,259
Total operating expenses 19,557 24,207
Loss from operations (19,278) (24,159)
Other income (expense):    
Interest expense, net (4,299) (1,643)
Other income 50 30
Net loss $ (23,527) $ (25,772)
Net loss applicable to common stockholders per basic common share:    
Basic (in dollars per share) $ (0.23) $ (0.32)
Diluted (in dollars per share) $ (0.23) $ (0.32)
Weighted average common shares outstanding:    
Basic (in shares) 100,462,262 81,009,268
Diluted (in shares) 100,462,262 81,009,268
[1] Amounts include depreciation and amortization as follows:
  Three Months Ended March 31,
  2023 2022
Cost of goods sold
 $ 936  $ 62 
Research and development
 566  312 
Selling, general and administrative
 1,956  167 
Total depreciation and amortization $ 3,458  $ 541 
[2] Amounts include stock-based compensation as follows:
  Three Months Ended March 31,
  2023 2022
Cost of goods sold
 $ 87  $ 5 
Research and development
 738  485 
Selling, general and administrative
 5,134  10,523 
Total stock-based compensation expense, net of amounts capitalized $ 5,959  $ 11,013